MedPath

estimation of leptin levels in chronic gum disease subjects

Phase 3
Completed
Conditions
Health Condition 1: K053- Chronic periodontitis
Registration Number
CTRI/2017/10/010171
Lead Sponsor
Dr Swet Nisha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

1.Subjects who are willing to give informed consent.

2.Subjects in the age group of 25 ââ?¬â?? 55 years.

3.Subjects who have at least 20 functional teeth

4.Subjects with Chronic Generalised Periodontitis. (Which is �30% of the sites showing �3-4mm of clinical attachment loss with radiographic evidence of bone loss.

5.Subjects with normal body mass index (BMI) (18.5-22.9 kg/meter square) according to the chart for the Asian population given by WHO

Exclusion Criteria

1.Subjects who are having Systemic diseases or are under regular medications for any systemic diseases.

2.Subjects who are on Anti-inflammatory/Anti-microbial therapy/mouthwashes or any vitamin supplements in the past 3 months.

3.Subjects who have undergone Periodontal Therapy in the last 6 months.

4.Pregnant or Lactating women.

5.Subjects who give a history of previous or current Smoking.

6.Subjects with Special Dietary requirements

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To evaluate levels of leptin and Total Antioxidant Capacity in patients with Chronic Periodontitis after Non Surgical TherapyTimepoint: baseline- subjects enrollment and saliva and serum sample collection. <br/ ><br>1 month recall clinical parameter measurement <br/ ><br>3 months recall reevaluation of saliva and serum samples . 6 months duration study
Secondary Outcome Measures
NameTimeMethod
to correlate the leptin levels and total antioxidant capacity in chronic generalised periodontitis patientsTimepoint: 3 months and 6 months- subjects enrollment and saliva and serum sample collection.
© Copyright 2025. All Rights Reserved by MedPath